Exchange: NASDAQ·Updated 07:46 PM EDT
NSPR logo

NSPR InspireMD Inc

$0.521
$0.041
(8.54%)
Today
Closed $0.521
$0.019
(3.65%)
After Hours
EarningsNov 10
Mkt Cap$22.31M
Vol327,215.00

About NSPR

InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Miami, FL.
54

Neutral Sentiment

How do you feel about NSPR?

LoyalShark
$NSPR Maybe a good time to start drinking the Kool Aid...or at least give it a very good thought. We either dance in the streets in 2027 or we die. Knowing a bit about the effort going into getting this to a new reallity...Ive started sipping.
4
GiveHerTheDD
$NSPR Day 7 of Q4 and 2 months after the expected August 2026 approval of the legacy system... Still nothing.
3
Markad0
$NSPR This is one prediction I'd hope to have missed. If I am going to invest more, it will be after the news of FDA approval of original delivery system or new (and any re-commercialization news and any forthcoming RS+Dilution crap. Saying nothing = doing nothing in the market's estimation, and for NSPR, at present, that means the one trick pony is stuck in the stable.
1
LoyalShark
$NSPR Starting to concern me how long it is taking to get FDA clearance on the legacy delivery system. There has to be something they are not telling us. It was used in the trials and in over 70,000 procedures world wide....and we are past the 'typical' timeframe for approval.
3
GiveHerTheDD
$NSPR Entering Q4 - critical time period that should have 2 major catalysts. Both catalysts essentially derisked and definitively happening. One in the next week, another in early November. I am personally hoping for the delivery system FDA approval to be announced in the next 16 hours 🤞🤞🤞
3
Threeways
$NSPR what a steal at this price. Bought more again today; it will be nice on the TCAR bounce buying here.
3
Jonnie5
$NSPR I think if the company issues more warrants this stock has a shot at a comeback. The lower the better.
3
GiveHerTheDD
$NSPR watched the ICCA webinar recording last week that focused on CGuard, both cas and tcar. Crazy how the data and products (current and future) kick ass yet priced as zero value to the share price. Upcoming catalysts should really finally turn this around and prompt a buyout to anyone that wants best in class cas and tcar stent and a future best in class cas and tcar delivery system. Way undervalued! Buyout estimates coming in around $500-$700m once de-risked (soon!)
3
LoyalShark
$NSPR We need to get the stock over $1.38 - give the warrant holders a reason to sell - ther warrants are worthless below $1.38 -- as shareholders we dont wat dilution at 80 cts....so lets get it above $1.38 so we have a reasonable amount of fund raising. As of the August filings --- NSPR has not touched their ATM. They have not sold any shares....as of August. TCAR approval expected first part of November - 7 weeks away. Not much new about the legacy delivery system ---- we need to know more about when that happens...or why it has not happened yet.
3
Carib74
$NSPR FDA approval will no longer save this company. They have basically zero cash runway for any launch and still lose money even they are selling. Why would anyone invest the millions it will take to successfully launch and turn profitable with this kind of incompetent organisation, why you would anyone buy this company to infect themselves with these people. still say bankruptcy and a sell off of the IP.
2
Threeways
$NSPR new October presentation is out. Nothing new from the previous presentation that I can remember. It would be nice to see them move up SwitchGuard to 1H 2027 so you have 4 catalyst back to back over the next 8 months but beggars can’t be choosers
2
Jonnie5
$NSPR wild ride to wait this long and see if Slosman ruined my life. Meanwhile he is rollerblading in South Beach drinking mojitos. Enjoy!
2
Markad0
$NSPR And, there it is. Under $.50 per share for a best in class tech device. All due to mismanagement of the creation and launch of the new delivery system for the US Market. Congratulations NSPR Leadership on being most un-inspiring with your ineffective address and resolution of this key issue, to date. Keep this up and absent of or inclusive of a reverse split, the stock will be between $.30-35 per share (or the reverse split equivalent) with tax loss selling by Dec 31.
1
Meterdoc
$NSPR don’t look at me, I’ve been warning against this cat turd for years. Some cheerleaders even poked at me for my number of followers and such. 😂😂 rah rah sis boom bah. This old, wise guy at the end of the bar doesn’t need to win a Stocktwits popularity contest 😂😂🍻
1
woodstockery
$NSPR astonishing. For something with so many positives they really managed to shit the bed 😂
1
DipBuyPro
If you like to find the runners early - Join the group of bulls below One of the best FREE small cap communities i know of 🔥 🫡💯 Everyone seems to catch that $NSPR early
Carib74
$NSPR calling anyone but a lawyer won't make any difference....this canoe is sinking and only con man Marvin has a lifejacket...the end is near
Threeways
$NSPR a big question mark is will doctors that were trained on the recalled delivery system need retrained on the original which wasn’t stated by Marvin.
RedDogSailor
$NSPR if I were a medical professional, considering adopting this technology for my hospital or my practice, I would reject it simply on the basis of the stock price and the obvious management incompetence.
RedDogSailor
$NSPR This guy is too cheap or stupid to invest a dime in IR With such a great story to tell…

Advertisement|Remove ads.